Corporate Partnering Opportunities
ExSAR is interested in discussing regional and global commercialization partnerships for its lead LOTS and Gaucher compounds. Please contact Dawne Miller at busdev@exsar.com if interested in this opportunity.

Fee-for-service-contracts
ExSAR has executed hundreds of studies for major pharmaceutical, biopharmaceutical and academic clients. ExSAR offers a collaborative and consultative approach, with verbal and written presentation of results. We strictly adhere to confidentiality obligations, and typical relationships are according to simple fee-based terms. We offer feasibility based arrangements as well as usage volume discounting. Scientific leadership includes Dr. Charles Cantor, Dr. William DeGrado, and Dr. S. Walter Englander, each members of the National Academy of Science. Projects are conducted under the supervision of Dr. Yoshitomo Hamuro. For additional information or to arrange a web based presentation, please contact Dawne Miller at busdev@exsar.com.

Discovery Collaboration
ExSAR’s recognized excellence in the application of H/D-Ex technology has made it possible to build and maintain a large network of drug discovery innovators. The extensive product development and commercialization experience of ExSAR’s senior management and ExSAR’s target validation technology together make ExSAR an extremely effective partner for academic based and otherwise early stage programs. ExSAR is actively seeking opportunities in diseases of conformation. Pharmacological chaperones currently represent an exciting and potentially relevant form of therapy for many of these types of diseases. Diseases of conformation include pathologies involving aggregation, i.e. Parkinson’s, Alzheimer’s and Transmissible Spongiform Encephalopathies. They also include diseases resulting from enzymatic deficiencies, i.e. Gaucher and Late-Onset Tay-Sachs diseases. If you would like to discuss co-drug development opportunities please contact Dawne Miller at busdev@exsar.com.

H/D Exchange Overview | H/D Exchange Science | H/D Exchange Applications | H/D Exchange Partnering Opportunities
Corporate Partnering Opportunities | Fee-for-service-contracts | Drug Discovery Collaboration